Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1968 1
1969 1
1970 3
1975 1
1987 1
1988 1
1991 1
1992 2
1993 1
1994 1
1995 2
1996 2
1997 1
1998 2
1999 2
2000 3
2001 3
2003 1
2004 1
2005 5
2006 3
2007 5
2008 6
2009 3
2010 11
2011 9
2012 11
2013 6
2014 15
2015 18
2016 10
2017 11
2018 13
2019 18
2020 18
2021 41
2022 22
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids.
Marsee A, Roos FJM, Verstegen MMA; HPB Organoid Consortium; Gehart H, de Koning E, Lemaigre F, Forbes SJ, Peng WC, Huch M, Takebe T, Vallier L, Clevers H, van der Laan LJW, Spee B. Marsee A, et al. Among authors: roos fjm. Cell Stem Cell. 2021 May 6;28(5):816-832. doi: 10.1016/j.stem.2021.04.005. Cell Stem Cell. 2021. PMID: 33961769 Free article. Review.
Human branching cholangiocyte organoids recapitulate functional bile duct formation.
Roos FJM, van Tienderen GS, Wu H, Bordeu I, Vinke D, Albarinos LM, Monfils K, Niesten S, Smits R, Willemse J, Rosmark O, Westergren-Thorsson G, Kunz DJ, de Wit M, French PJ, Vallier L, IJzermans JNM, Bartfai R, Marks H, Simons BD, van Royen ME, Verstegen MMA, van der Laan LJW. Roos FJM, et al. Cell Stem Cell. 2022 May 5;29(5):776-794.e13. doi: 10.1016/j.stem.2022.04.011. Cell Stem Cell. 2022. PMID: 35523140 Free article.
[Robotic-assisted radical prostatectomy].
Thomas C, Neisius A, Roos FC, Hampel C, Thüroff JW. Thomas C, et al. Among authors: roos fc. Urologe A. 2015 Feb;54(2):178-82. doi: 10.1007/s00120-014-3665-3. Urologe A. 2015. PMID: 25616764 Review. German.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
[Asymptomatic kidney stones: active surveillance vs. treatment].
Neisius A, Thomas C, Roos FC, Hampel C, Fritsche HM, Bach T, Thüroff JW, Knoll T. Neisius A, et al. Among authors: roos fc. Aktuelle Urol. 2015 Sep;46(5):391-4. doi: 10.1055/s-0035-1559651. Epub 2015 Sep 17. Aktuelle Urol. 2015. PMID: 26378390 Review. German.
Drug-induced hepatotoxicity.
De Roos FJ, Hoffman RS. De Roos FJ, et al. N Engl J Med. 1996 Mar 28;334(13):863; author reply 864. doi: 10.1056/NEJM199603283341313. N Engl J Med. 1996. PMID: 8596560 Free article. No abstract available.
215 results